Fact-checked by Grok 2 weeks ago

Heart block

Heart block, also known as atrioventricular (AV) block, is a conduction disorder in which the electrical signals that regulate the are delayed or completely blocked as they travel from the heart's upper chambers (atria) to the lower chambers (ventricles), potentially leading to an irregular or slowed . This condition disrupts the normal synchronization between atrial and ventricular contractions, which can range from mild and asymptomatic to severe and life-threatening if untreated. Heart block is classified into three main degrees based on the severity of the conduction impairment. First-degree heart block involves a prolonged delay in signal transmission, typically manifesting as a longer than 200 milliseconds on an electrocardiogram (ECG), but all signals eventually reach the ventricles. Second-degree heart block is characterized by intermittent failure of signals to conduct, subdivided into Mobitz type I (with progressive lengthening before a dropped beat) and Mobitz type II (sudden dropped beats without prior lengthening), which carries a higher of progression. Third-degree, or complete, heart block represents total between atrial and ventricular activity, where no atrial impulses reach the ventricles, resulting in independent rhythms and often requiring urgent intervention. These types can occur congenitally or be acquired later in life. Common causes of heart block include age-related degeneration of the conduction system, , certain medications (such as beta-blockers or ), electrolyte imbalances, and congenital factors like maternal . Risk factors encompass older age, family history of cardiac conditions, and underlying heart diseases such as or valvular disorders. Symptoms vary by degree but may include fatigue, dizziness, fainting (syncope), , and , with complete block potentially causing hemodynamic instability or sudden cardiac arrest. Diagnosis primarily relies on a 12-lead ECG to identify characteristic patterns, supplemented by ambulatory monitoring (e.g., Holter), exercise testing, or electrophysiological studies for confirmation. may assess structural heart issues contributing to the block. depends on severity and symptoms: suffices for first-degree block, while second- and third-degree blocks often necessitate permanent implantation to restore coordinated heartbeats, alongside addressing reversible causes like medication adjustments. In acute settings, temporary pacing or medications may stabilize the patient. Early management improves prognosis, particularly for complete heart block, where untreated five-year survival is approximately 37%.

Cardiac Conduction System

Anatomy

The sinoatrial (SA) node, the heart's primary pacemaker, is a small, elongated structure located at the junction of the superior vena cava and the right atrium, typically measuring about 10-20 mm in length and embedded within the atrial wall. It consists of specialized autorhythmic cells, including nodal (P) cells and transitional (T) cells, which have fewer myofibrils than typical cardiomyocytes and are rich in glycogen, enabling spontaneous depolarization. Histologically, the SA node is insulated by dense connective tissue that separates it from surrounding atrial myocardium, ensuring directed impulse propagation. The atrioventricular () node serves as the electrical gateway between the atria and ventricles and is positioned in the lower right atrium within the triangle of Koch, bounded by the tendon of Todaro, the septal leaflet of the , and the ostium. This compact structure, approximately 1-5 mm in size, features specialized nodal cells with sparse myofibrils and prominent fibrous insulation provided by the central fibrous body of the , which delays conduction to allow atrial contraction completion. The AV node's histology includes transitional cells connecting to atrial myocardium and penetrating fibers that form the initial segment of the His bundle. Distal to the AV node, the bundle of His (or AV bundle) emerges as an elongated cord of specialized conduction fibers, about 1-2 cm long, penetrating the fibrous cardiac skeleton at the top of the interventricular septum to connect with the bundle branches. It comprises Purkinje-type cells and slender transitional cells, with minimal fibrous encapsulation to facilitate rapid signal transmission. The His bundle bifurcates into the left and right bundle branches: the right branch courses along the right interventricular septum toward the apex, while the left branch, thicker and divided into anterior and posterior fascicles, traverses the left septum. These branches distribute into an extensive network of , which ramify subendocardially through the ventricular myocardium from apex to base, consisting of large, pale-staining cells with abundant , few myofibrils, and peripheral nuclei for swift impulse conduction.

Physiology

The sinoatrial (SA) node, the heart's primary , exhibits through spontaneous generation of action potentials at a rate of 60 to 100 beats per minute, initiating the normal . This stems from phase 4 diastolic depolarization, where the slowly rises due to decaying outward currents and inward currents via ion channels, including the hyperpolarization-activated funny current (I_f, primarily sodium influx) and T-type calcium channels. Upon reaching threshold (around -40 mV), phase 0 depolarization occurs through rapid activation of L-type voltage-gated calcium channels, allowing calcium influx to propagate the impulse, distinct from the sodium-driven phase 0 in contractile myocytes. The generated impulse spreads rapidly across the atrial myocardium via gap junctions at conduction velocities of 0.5 to 1 m/s, reaching the atrioventricular (AV) node within about 90 milliseconds. At the AV node, physiological conduction is intentionally slowed, introducing a delay of approximately 0.1 seconds due to reliance on slower calcium-dependent action potentials and fewer gap junctions in nodal cells. This delay coordinates atrial emptying prior to ventricular activation. From the AV node, the impulse proceeds through the penetrating , dividing into left and right bundle branches, and then into the Purkinje fiber network, which facilitates rapid conduction at velocities up to 2 m/s to ensure near-simultaneous ventricular from to epicardium and to . After , cardiac cells enter periods that enforce sequential activation and prevent premature excitations. The , spanning phases 0 through most of phase 3 (lasting 200-250 ms in ventricular myocytes), inactivates sodium channels, rendering the tissue inexcitable to maintain the heart's rhythm. The following relative , during late phase 3, partially restores excitability but requires a stronger stimulus for as efflux continues. Collectively, these periods promote unidirectional impulse travel and inhibit re-entrant loops by allowing full recovery before subsequent impulses. This orderly propagation synchronizes atrial and ventricular contractions, with atrial preceding ventricular to maximize filling. The atrial contribution, known as the "atrial kick," boosts ventricular by 20-30% at rest, thereby increasing and without excessive energy expenditure.

Pathophysiology

Mechanisms of Block

Heart block encompasses impaired electrical conduction within the atrioventricular () conduction , occurring at the AV junction or infranodal regions below the His bundle, which leads to delayed or absent activation of the ventricles. This disruption prevents normal propagation of impulses from the atria to the ventricles, potentially causing or if uncompensated. The normal conduction pathway, originating from the sinoatrial (SA) node through the atria to the AV node and His-Purkinje , serves as the baseline for these impairments. Various mechanisms underlie heart block, including prolongation of the refractory period in conduction tissues, structural damage to the pathways, and influences. Increased refractory periods can arise from electrolyte imbalances, such as , where elevated extracellular potassium depolarizes the resting , slowing conduction velocity and extending the in atrial, nodal, and ventricular tissues. Structural damage, often involving or degeneration of the conduction fibers, physically interrupts impulse transmission, particularly in aging or ischemic hearts where sclerotic changes accumulate in the AV node or His-Purkinje system. influences, such as heightened , selectively prolong refractoriness in the AV node by enhancing acetylcholine-mediated hyperpolarization, thereby delaying AV conduction without necessarily affecting the infranodal regions. The location of the block determines its specific physiological impact. AV junctional block interrupts transmission from atria to ventricles, compromising atrioventricular synchrony and leading to dissociated atrial and ventricular rhythms where atrial contractions may not effectively preload the ventricles. Infra-Hisian block, occurring distal to the His bundle in the , more severely affects ventricular activation, often producing wide QRS complexes and predisposing to unstable ventricular escape rhythms due to the slower intrinsic rates and broader conduction delays in these distal tissues. When higher-order s fail, subsidiary escape rhythms emerge to maintain . The AV junctional pacemaker, with an intrinsic rate of 40-60 beats per minute, can assume control in proximal AV blocks, generating narrow QRS complexes if the His-Purkinje system is intact. In more distal infra-Hisian blocks, ventricular escape rhythms predominate at slower rates of 20-40 beats per minute, often with wide QRS due to reliance on Purkinje or myocardial , which provides less reliable and hemodynamically suboptimal pacing. These escape mechanisms highlight the of the conduction system, where lower pacemakers activate only after prolonged suppression of superior sites.

Classification

Heart block is classified primarily by anatomical location within the AV conduction system and by the degree of conduction impairment, which determines and management implications. Blocks at the , intra-Hisian (within the His bundle), and infra-Hisian regions (below the His bundle, involving the bundle branches and ) represent distinct subtypes, with degrees ranging from partial delays to complete interruption. This taxonomic approach distinguishes benign, often reversible forms from those prone to progression and hemodynamic instability. Atrioventricular blocks are subdivided by degree of impairment in atrial-to-ventricular impulse transmission. First-degree AV block is characterized by a prolonged exceeding 200 milliseconds with consistent 1:1 conduction, representing a uniform delay usually at the AV nodal level without dropped beats. Second-degree AV block encompasses intermittent failure of conduction: Type I (Wenckebach) involves progressive prolongation culminating in a non-conducted P wave and dropped QRS complex, often supranodal in location and associated with vagal influences; Type II features a constant with sudden, intermittent non-conducted P waves, typically infra-nodal and signaling higher risk of progression. Third-degree, or complete, AV block entails total dissociation between atrial (P waves) and ventricular () activity, with no conducted impulses and independent rhythms in each chamber, necessitating an escape rhythm for ventricular . Infra-Hisian blocks involve conduction disturbances distal to the His bundle, affecting the bundle branches or Purkinje system, and often result in wide QRS escape rhythms due to slowed ventricular activation via myocardial fibers rather than the specialized conduction pathway. These blocks are distinguished from more proximal forms by their association with structural degeneration, poor response to , and propensity for rapid progression to complete AV block, frequently requiring permanent pacing.

Epidemiology

Prevalence

Heart block, encompassing atrioventricular () and sinoatrial (SA) blocks, exhibits low overall in the general population, with advanced forms being particularly rare. The of third-degree (complete) AV block is estimated at 0.02% in the United States and 0.04% worldwide. First-degree AV block is more common, occurring in approximately 1-1.5% of individuals under age 60 and up to 5% in men over age 60. Second- and third-degree AV blocks together have a of 0.2-1.2% in screened populations. Prevalence increases significantly with age, reflecting degenerative changes in the conduction system, and is generally higher in males. In individuals aged 60 and older, the overall prevalence of any AV block rises to about 1.8%, compared to 0.27% in those aged 18-39. For high-grade AV block (second- or third-degree), prevalence is elevated in the elderly. SA block, a component of , is less frequently reported but contributes to the broader category of bradyarrhythmias, with affecting approximately 0.2% of people over age 65. SA block is often underdiagnosed due to its intermittent nature and overlap with other sinus pauses. Global variations in heart block prevalence are influenced by differences in population aging and underlying cardiovascular disease burdens. Regions with older demographics, such as and , report higher rates of age-related AV block compared to , where younger populations predominate.

Risk Factors

Age is the strongest for developing heart block, with incidence increasing markedly due to age-related degenerative changes in the , such as idiopathic fibrosis and sclerosis of the and bundle branches. The risk of atrioventricular block rises with advancing , with a of 1.34 per 5-year increment in a large population-based . This age-related progression contributes to higher prevalence in older adults, where alone affects approximately 5.3% of individuals, particularly males. Comorbid cardiovascular conditions significantly predispose individuals to heart block by promoting structural and functional damage to the conduction pathways. Ischemic heart disease, particularly following , elevates the risk by approximately 3.5-fold (hazard ratio 3.54, 95% 1.33-9.42). Similarly, congestive increases the risk by about 3.3-fold (hazard ratio 3.33, 95% 1.10-10.09). and further amplify vulnerability; elevated systolic (hazard ratio 1.22 per 10-mm Hg increase) and fasting glucose levels (hazard ratio 1.22 per 20-mg/dL increase) are independently associated with , with population-attributable risks of 47% and 11%, respectively. Certain medications commonly used for cardiovascular conditions can induce reversible atrioventricular block by slowing conduction through the . Beta-blockers, non-dihydropyridine (such as verapamil and ), and are frequent culprits, accounting for up to 54% of drug-related atrioventricular block cases in clinical series, with resolution often occurring upon discontinuation in a majority of patients. These effects are dose-dependent and more pronounced in individuals with underlying conduction abnormalities. Genetic predispositions, though rare, can lead to progressive forms of heart block, particularly in younger individuals. Lev-Lenègre disease, an inherited condition caused by mutations in the gene encoding the cardiac , results in idiopathic progressive cardiac conduction defect and is a notable example of such syndromes. This autosomal dominant disorder predisposes affected families to requiring implantation at relatively early ages.

Etiology

Acquired Causes

Acquired heart block refers to disruptions in the that develop after birth due to various pathological processes, distinct from congenital origins. These causes often involve ischemia, , iatrogenic factors, or metabolic derangements that impair atrioventricular () function or infranodal conduction pathways. While some acquired blocks are transient and reversible upon addressing the underlying trigger, others may progress to permanent conduction defects requiring intervention. Ischemic heart disease, particularly acute (MI), is a leading cause of acquired block, accounting for approximately 5-13% of third-degree blocks in affected patients. In inferior wall MI, which often involves the supplying the , ischemia leads to transient or persistent nodal block due to heightened and direct ischemic damage. Anterior wall MI, by contrast, more commonly affects the bundle branches below the , resulting in wider QRS complexes and higher mortality risk from extensive septal . Inflammatory and infectious conditions can infiltrate or inflame the conduction system, producing blocks that range from first-degree to complete AV dissociation. , caused by , frequently manifests as AV block in early disseminated stages, with approximately 80-90% of cases showing conduction abnormalities; these are typically transient, resolving with antibiotics, though rare permanent damage occurs. , often viral in origin, induces and lymphocytic infiltration around the AV node or His-Purkinje system, leading to high-grade blocks in up to 10-20% of severe cases, with potential for reversibility if inflammation subsides promptly. , an autoimmune response to , classically prolongs the via inflammation in the conduction tissues, but higher-degree blocks are uncommon and usually resolve with anti-inflammatory therapy. Iatrogenic causes arise from therapeutic interventions that mechanically or pharmacologically disrupt conduction. Post-cardiac surgery, particularly aortic or replacement, complete AV block develops in 3-6% of cases due to , , or direct to the perivalvular conduction tissues, with higher rates (up to 10%) in combined procedures. Drug toxicities, especially from AV nodal blocking agents like beta-blockers, non-dihydropyridine (e.g., verapamil), , and class I/III antiarrhythmics (e.g., , ), prolong the or induce higher-grade blocks by slowing nodal recovery or enhancing refractoriness, often reversible upon discontinuation but with recurrence risk in susceptible patients. Metabolic imbalances further contribute to acquired conduction delays by altering membrane potentials or myocardial excitability. , typically at levels exceeding 6.5 mEq/L, depresses phase 0 of the action potential in and ventricular myocytes, leading to PR prolongation, widened QRS, and progression to complete heart block; this is often seen in renal failure and reverses with potassium correction. Hypothyroidism slows AV conduction through reduced sympathetic tone, myocardial hypothyroidism-induced , and bradycardic effects, manifesting as first- or second-degree block in severe cases, which generally improves with thyroid hormone replacement.

Congenital Causes

Congenital heart block, also known as congenital atrioventricular (AV) block, is a rare condition with an incidence of approximately 1 in 15,000 to 20,000 live births, most cases presenting as isolated complete AV block without other cardiac anomalies. This form of heart block arises during fetal development and is typically diagnosed prenatally or shortly after birth through fetal echocardiography or electrocardiography. A primary congenital cause is autoimmune-mediated heart block linked to maternal systemic or other diseases, where transplacental passage of anti-Ro/SSA antibodies targets fetal cardiac conduction tissue, leading to inflammation and fibrosis of the AV node. Fetuses exposed to these maternal autoantibodies face a 2-5% risk of developing congenital AV block, with the majority of affected cases manifesting as irreversible third-degree (complete) block by 16-24 weeks of gestation. Structural congenital heart defects are associated with 30-50% of congenital heart block cases, often involving abnormalities that disrupt the normal development of the conduction system, such as atrial septal defects (ASD), ventricular septal defects (VSD), or more complex lesions like atrioventricular septal defects. In these instances, the heart block may result from malalignment or hypoplasia of the AV node during embryogenesis, exacerbating the conduction delay. Genetic mutations also contribute to congenital heart block, particularly in familial forms. Mutations in the gene, which encodes the cardiac Nav1.5, are implicated in progressive familial heart block type IA, where heterozygous loss-of-function variants lead to impaired conduction velocity and progressive AV block starting or early childhood.

Clinical Features

Symptoms

First-degree atrioventricular (AV) block is typically asymptomatic, as the conduction delay does not significantly impair cardiac output or heart rate. Similarly, many cases of second-degree type I (Mobitz I or Wenckebach) AV block remain asymptomatic, particularly when the block is intermittent and does not lead to substantial bradycardia. In contrast, second-degree type II (Mobitz II) AV block and third-degree (complete) AV block often produce noticeable symptoms due to more pronounced conduction failure and resultant bradycardia, typically with ventricular rates below 50 beats per minute. Patients commonly report fatigue, dizziness, and syncope, with the latter manifesting as sudden fainting episodes known as Stokes-Adams attacks, triggered by transient drops in cardiac output. These symptoms arise from inadequate perfusion to vital organs during periods of slowed or irregular ventricular response. Overall, symptom severity correlates with the degree of block, as higher-grade blocks more frequently result in and heart failure-like presentations, including dyspnea on exertion and easy fatigability.

Physical Examination

Physical examination in patients with heart block often reveals signs related to impaired atrioventricular conduction, particularly in second- and third-degree blocks, where objective findings can indicate the severity of the conduction disturbance. , defined as a less than 60 beats per minute, is a hallmark finding in advanced heart block due to delayed or blocked transmission from the atria to the ventricles, leading to a slow ventricular response. In third-degree (complete) heart block, atrioventricular may produce intermittent in the jugular venous pulse, resulting from atrial contraction against a closed when atria and ventricles contract simultaneously. These waves appear as prominent, irregular pulsations in the neck veins and are a key bedside clue to complete dissociation. Pulse examination typically shows irregularities in second-degree heart block, characterized by periodic pauses corresponding to non-conducted P waves, creating a pattern of grouped beating; for instance, in Mobitz type I (Wenckebach), the pauses follow progressive lengthening of the , while Mobitz type II features sudden dropped beats without prior prolongation. In cases of varying conduction ratios, such as 2:1 or 3:2 , the may exhibit alternating strong and weak beats due to differences in ventricular filling and . The overall rate remains bradycardic, and regularity is preserved in third-degree block at the escape rhythm , though intensity may vary slightly with hemodynamic effects. In symptomatic patients with significant heart block, signs of reduced are evident, including from inadequate and cool, clammy extremities reflecting peripheral and hypoperfusion. These findings are more pronounced in acute or severe cases where compromises systemic . If heart block is associated with underlying structural heart disease, such as valvular or , auscultation may reveal murmurs, including systolic or diastolic types depending on the lesion. Auscultation of heart sounds occasionally uncovers rare additional findings, such as an S3 or S4 gallop, attributable to ventricular dyssynchrony in blocks with wide QRS complexes or concurrent , though these are uncommon and nonspecific. Variable intensity of the first heart sound (S1) may also be noted in complete heart block due to differing atrioventricular valve positions at ventricular contraction. Overall, the provides vital clues to hemodynamic stability but requires electrocardiographic confirmation for definitive .

Diagnosis

Electrocardiography

is the primary diagnostic tool for identifying heart block, revealing characteristic patterns of atrioventricular () conduction delays or dissociations through analysis of , , and . Standard 12-lead ECG recordings at 25 mm/s speed allow measurement of intervals, with the defined as the time from the onset of the to the onset of the . First-degree AV block is diagnosed when the PR interval is prolonged beyond 200 ms, yet every atrial impulse () conducts to the ventricles, resulting in 1:1 conduction without dropped beats. This prolongation reflects delayed conduction through the node or His-Purkinje system but does not impair overall rhythm regularity. Second-degree AV block manifests as intermittent failure of atrial impulses to conduct to the ventricles and is subclassified into Mobitz type I and type II based on behavior. In Mobitz type I (Wenckebach), there is progressive lengthening of the across consecutive beats until a P wave is not followed by a QRS complex, producing a pattern of grouped beating; the following the dropped beat shortens, and atrial rate remains constant below 100 bpm. This type typically originates in the node and is associated with narrow QRS complexes. In Mobitz type II, the remains fixed before and after the nonconducted P wave, with sudden drops of QRS complexes; it often features wide QRS complexes (>120 ms) indicating infranodal involvement. Third-degree AV block, also known as complete heart block, shows complete dissociation between P waves and QRS complexes, with no atrial impulses conducting to the ventricles. P waves march independently at the atrial rate (typically 60-100 ), while the ventricular rate is slower, driven by an escape rhythm from the junction (40-60 bpm) or ventricles (30-40 bpm), often with wide QRS if ventricular escape predominates.

Additional Tests

Additional tests beyond electrocardiography are essential for evaluating the extent of heart block, correlating symptoms with arrhythmias, localizing conduction abnormalities, identifying structural heart disease, and detecting reversible etiologies. These supplementary investigations help guide management decisions, particularly in cases of intermittent or symptomatic blocks. Ambulatory electrocardiographic , such as 24- to 48-hour Holter , is recommended to capture intermittent heart block episodes that may be missed on a resting ECG, especially in patients with daily symptoms. For less frequent s, extended with event recorders (up to 30-90 days) or implantable loop recorders (beyond 2 years) increases diagnostic yield, though overall detection of significant bradyarrhythmias remains below 15%. Exercise testing is useful for assessing atrioventricular conduction during , particularly in patients with suspected exercise-induced or symptoms provoked by exertion (Class IIa recommendation). It can reveal progression to higher-degree AV with increased heart rates, helping differentiate infranodal from nodal conduction issues, though it should be performed cautiously in symptomatic or high-risk patients. Invasive studies are indicated to map the site of conduction delay in symptomatic patients where non-invasive tests are inconclusive, providing Class I recommendation for assessing atrioventricular conduction. These studies measure intervals such as the HV interval, where a value exceeding 55 ms suggests infra-Hisian , and prolongation to 70 ms or greater indicates high risk for progression to complete heart . Diagnostic yield varies from 12% to 80%, making them particularly useful in syncope with suspected conduction disease or post-procedural scenarios like . Echocardiography is routinely performed to evaluate for structural causes of heart block, carrying a Class I recommendation for identifying conditions such as or valvular disease that may contribute to conduction abnormalities. Transthoracic or transesophageal approaches assess left ventricular function and valvular integrity, offering prognostic insights in conduction disorders. Blood tests target reversible causes and are selected based on clinical suspicion, with Class I recommendation for electrolytes and to detect imbalances like or acute ischemia. and serology for receive Class IIa support, while autoimmune markers may be pursued in suspected inflammatory conditions. Directed testing avoids unnecessary comprehensive panels, focusing on etiologies like or .

Management

Conservative Approaches

Conservative approaches to managing heart block primarily involve non-invasive strategies aimed at , addressing underlying reversible factors, and providing temporary symptomatic relief, particularly for first-degree atrioventricular () block and type I second-degree (Mobitz I) block. For patients with first-degree block or type I second-degree block, observation with regular follow-up electrocardiograms (ECGs) is recommended to for progression, as these conditions often do not require intervention and permanent pacing is not indicated. Routine clinical follow-up every 3 to 6 months, including annual 12-lead ECGs and possibly 24- to 48-hour Holter if symptoms arise, helps ensure stability without unnecessary . Correction of reversible causes is a of , focusing on discontinuing offending medications such as beta-blockers, , or that may exacerbate AV conduction delays, as well as treating electrolyte imbalances (e.g., or ) or infections like . Identifying and resolving these factors through patient history, tests, and vital sign monitoring can often restore normal conduction without further intervention, preventing progression to higher-degree blocks. In acute settings with symptomatic vagally mediated AV block at the nodal level, atropine administered intravenously at a dose of 1 mg (repeatable every 3 to 5 minutes up to a total of 3 mg) can temporarily enhance sinoatrial and AV nodal rates by blocking vagal effects, providing short-term relief while addressing the underlying cause. Lifestyle modifications play a supportive role, particularly in individuals with high such as athletes, where avoiding excessive vagal triggers like prolonged Valsalva maneuvers or high-intensity endurance activities that heighten parasympathetic activity may reduce episode frequency; general advice includes minimizing stress, , and intake to support overall cardiac stability.02560-8/fulltext)

Interventional Therapies

Interventional therapies for heart block primarily involve device-based and invasive procedures to restore effective cardiac conduction or rhythm when conservative measures are insufficient. Pacemaker implantation is the cornerstone treatment for advanced forms of atrioventricular (AV) block, particularly when symptoms such as syncope, fatigue, or hemodynamic instability are present. According to the 2018 ACC/AHA/HRS Guideline, permanent pacing is recommended (Class I, Level of Evidence B) for symptomatic second-degree AV block Mobitz type II, third-degree AV block, or infra-Hisian block, as these conditions carry a high risk of progression to complete heart block and sudden cardiac events. In asymptomatic cases of third-degree or advanced second-degree AV block with documented infra-Hisian conduction delay, implantation is also indicated (Class I, Level of Evidence B-NR) due to the potential for asystole or ventricular arrhythmias. Pacemaker selection depends on anatomy, comorbidities, and the need for atrioventricular synchrony. Dual-chamber s (DDD mode) are preferred (Class I, Level of Evidence B-R) for most s with AV block, as they maintain physiologic timing between atrial and ventricular contractions, reducing the risk of pacemaker syndrome and compared to single-chamber ventricular pacing (VVI mode). VVI pacing is reasonable (Class IIa, Level of Evidence B-R) in frail elderly s or those with chronic , where atrial synchronization is not feasible, offering simplicity and lower procedural complexity. Implantation timing is critical; for instance, in postoperative settings after , permanent pacing is advised if high-grade AV block persists beyond 7-14 days, with earlier intervention considered for symptomatic cases. Temporary pacing serves as a bridge in acute scenarios, such as hemodynamic instability from drug-induced or ischemic AV block, prior to permanent placement. Transvenous temporary pacing is recommended (Class I, Level of Evidence B-NR) for urgent management of acute high-degree AV block, providing reliable ventricular capture while minimizing infection risk through short-term use. External (transcutaneous) pacing may be employed (Class IIa, Level of Evidence B-NR) as an immediate, non-invasive option in emergencies when vascular access is delayed, though its use is limited by patient discomfort and lower efficacy for prolonged support. Catheter ablation is infrequently utilized for heart block but may address rare focal etiologies, such as post-surgical injury to conduction pathways or tracts causing intermittent block. In select cases of symptomatic block due to a ventricular nodal pathway, radiofrequency can alleviate the conduction abnormality (success rate >90% in reported series), potentially avoiding dependency.30998-0/fulltext) Surgical interventions are reserved for refractory or complex scenarios; node ablation combined with permanent pacing is indicated (Class I, Level of Evidence B-NR) for patients with tachycardia-bradycardia syndrome or refractory where rate control is needed, intentionally creating complete block to prevent rapid ventricular rates. In congenital heart block associated with structural defects, surgical repair of the underlying anomaly (e.g., during correction of atrioventricular septal defects) may resolve or prevent progression of block, with epicardial leads placed intraoperatively if persistent conduction issues arise.

Prognosis

Outcomes by Type

First-degree atrioventricular (AV) block is generally considered benign, with the majority of patients remaining asymptomatic and experiencing no increased mortality when isolated from other cardiac conditions. Studies indicate that while most cases do not progress to higher-degree blocks, prolonged intervals (>200 ms) are associated with a 1.44-fold adjusted risk of all-cause mortality and a higher incidence of (adjusted 2.06). In the absence of symptoms or underlying heart disease, long-term outcomes are favorable, with rare need for intervention. Prognosis varies by block location; AV nodal blocks generally have better outcomes than infranodal blocks, which are more likely to progress. Second-degree AV block encompasses two subtypes with distinct prognoses. Mobitz type I (Wenckebach) block typically has an excellent prognosis, particularly when reversible due to factors like medications or increased , and rarely progresses to complete heart block in asymptomatic individuals without structural heart disease. It often resolves when the underlying cause is addressed, such as during recovery from acute or electrolyte correction. In contrast, Mobitz type II block carries a higher , with progression to third-degree AV block occurring in more than 50% of cases, especially if infranodal in location, leading to increased morbidity and potential sudden cardiac events without pacing. Outcomes improve substantially with permanent implantation, mitigating the risk of hemodynamic compromise. Prognosis varies by block location; AV nodal blocks generally have better outcomes than infranodal blocks, which are more likely to progress. Third-degree (complete) AV block represents the most severe form, with poor if untreated due to profound and risk of ; untreated cases have high mortality, with approximately 37% five-year survival, heavily influenced by comorbidities and etiology, such as lower rates in acute settings. With permanent therapy, survival improves markedly, achieving 85% at one year and 52% at five years for isolated cases, though rates vary by patient age and coexisting conditions. Prompt pacing is essential, as it significantly reduces mortality and restores near-normal in otherwise healthy individuals. varies by block location; AV nodal blocks generally have better outcomes than infranodal blocks, which are more likely to progress.

Complications

Untreated infra-Hisian heart block carries a significant of sudden cardiac due to episodes of or associated ventricular arrhythmias, with studies indicating an annual incidence of approximately 1-2% in the absence of pacing. This is particularly elevated in conditions involving bifascicular or complete infra-Hisian conduction delay, where unreliable escape rhythms can lead to hemodynamic collapse. implantation substantially mitigates this danger by maintaining atrioventricular synchrony and preventing bradycardic pauses. Chronic from can precipitate through reduced and ventricular dyssynchrony, with up to 23% of patients with high-degree block presenting with decompensated , often linked to impaired left ventricular compliance and diastolic rather than systolic dysfunction alone. This progression underscores the need for timely intervention to restore physiologic heart rates and preserve myocardial function. Pacemaker therapy, while effective, introduces device-related complications in approximately 5% of implants, including lead fractures and mechanical failures that may necessitate revision. remains a critical concern, occurring in 1-2% of procedures, with rates reaching 2.2% within 90 days post-implantation and potentially leading to systemic involvement or device explantation. Inappropriate pacing or shocks, though less common in pure pacemakers, can arise from lead dislodgement or sensing errors, contributing to overall morbidity.

References

  1. [1]
    Arrhythmias - Conduction Disorders | NHLBI, NIH
    Mar 24, 2022 · A conduction disorder, also known as heart block, is a problem with the electrical system that controls your heart's rate and rhythm.
  2. [2]
    Atrioventricular Block - StatPearls - NCBI Bookshelf
    Feb 12, 2024 · Atrioventricular block represents a delay or disturbance in the transmission of an impulse from the atria to the ventricles.
  3. [3]
    Physiology, Sinoatrial Node - StatPearls - NCBI Bookshelf
    The main function of the SA node is to act as the heart's normal pacemaker. It initiates an action potential that results in an electrical impulse traveling ...
  4. [4]
    Histology, Heart - StatPearls - NCBI Bookshelf - NIH
    Jan 2, 2023 · As the fibers travel inferiorly, they penetrate the central fibrous body of the cardiac skeleton to form the bundle of His.
  5. [5]
    Atrioventricular Node - StatPearls - NCBI Bookshelf - NIH
    The atrioventricular (AV) node is a small structure in the heart, located in the Koch triangle,[1] near the coronary sinus on the interatrial septum.Definition/Introduction · Issues of Concern · Clinical SignificanceMissing: position | Show results with:position
  6. [6]
    Physiology, Bundle of His - StatPearls - NCBI Bookshelf
    May 1, 2023 · The bundle of His is an elongated segment connecting the AV Node and the left and right bundle branches of the septal crest.Introduction · Cellular Level · Development · Pathophysiology
  7. [7]
    Overview of Cardiac Conduction - Conduction System Tutorial
    The sinoatrial node is located in the upper part of the right atrium in the healthy heart, and serves as the natural pacemaker (Figure 1).
  8. [8]
    Sinoatrial Node Action Potentials - CV Physiology
    SA nodal action potentials are divided into three phases. Phase 4 is the spontaneous depolarization (pacemaker potential) that triggers the action potential ...Missing: automaticity | Show results with:automaticity
  9. [9]
    Normal and Abnormal Electrical Conduction - CV Physiology
    The conduction of electrical impulses in the heart occurs cell-to-cell and highly depends on the rate of cell depolarization in both nodal and non-nodal cells.
  10. [10]
    Physiology, AV Junction - StatPearls - NCBI Bookshelf
    The AV junction plays a significant role in the propagation of a signal from the sinoatrial (SA) node to the ventricles.Missing: 0.1-0.2 seconds
  11. [11]
    Effective Refractory Period - CV Pharmacology
    The length of the refractory period limits the frequency of action potentials (and therefore contractions) that can be generated by the heart. Many ...
  12. [12]
    Cardiac Cycle - Atrial Contraction (Phase 1) - CV Physiology
    Atrial contraction normally accounts for about 10% of left ventricular filling when a person is at rest because most of ventricular filling occurs before atrial ...
  13. [13]
  14. [14]
    Hyperkalemia: pathophysiology, risk factors and consequences
    Dec 4, 2019 · ... refractory period increases, promoting cardiac conduction blocks. As depolarization merges with (premature) repolarization, there may be Q–T ...
  15. [15]
    Sinus Node Dysfunction - StatPearls - NCBI Bookshelf
    Sinus node dysfunction results from the abnormal automaticity, conduction, or both of the sinoatrial node and surrounding tissues. Both could result from ...
  16. [16]
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management ...
    Nov 6, 2018 · Bradycardia can be broadly classified into 2 general categories: SND and atrioventricular block. The associated wide range of clinical ...<|control11|><|separator|>
  17. [17]
    Sinoatrial Exit Block - ECG Library Diagnosis - LITFL
    Oct 8, 2024 · SA Exit Block Overview: Sinoatrial exit block is due to failed propagation of pacemaker impulses beyond the SA node.
  18. [18]
    Heart Block and Conduction Abnormalities - LITFL
    Nov 3, 2020 · Heart Block and Conduction Abnormalities with first, second, third degree blocks; and fascicular blocks.
  19. [19]
    Heart Block: Types, Causes, Symptoms, Treatment - Healthline
    Oct 24, 2022 · The prevalence of first-degree heart block in people under age 60 is 1% to 1.5%. Second degree. Second-degree heart block is categorized in ...
  20. [20]
    First-Degree Atrioventricular Block - Medscape Reference
    Jun 19, 2024 · The overall prevalence is 1.13 cases per 1,000 lives. In a study of 2,123 patients aged 20-99 years, first-degree AV block was more prevalent ...Background · Pathophysiology · Etiology · Epidemiology
  21. [21]
    Atrioventricular (AV) Conduction Disorders - DynaMed
    Oct 26, 2023 · 1.13 per 1,000 person-years incidence of first-degree AV block ... 0.2%-1.2% prevalence of second-degree or third-degree AV block at ...
  22. [22]
    Prevalence and risk factors of atrioventricular block among 15 ... - NIH
    Jun 11, 2021 · It was lower than the prevalence reported in the Michigan general population 0.02–0.04% [17] and Reykjavik general population 0.04% [18].
  23. [23]
    Arrhythmias in Patients ≥80 Years of Age: Pathophysiology ... - JACC
    ... AV block is 0.6% (0% to 4.5%), with a mean prevalence of 2.1% (0% to 11.9%) (31). Although the incidence of AV block is low, many elderly patients are ...
  24. [24]
    Sick Sinus Syndrome - DynaMed
    Mar 7, 2022 · ... sinoatrial exit block, and alternate episodes of bradycardia and tachycardia. ... The reported prevalence is 1 in 600 (0.2%) patients > 65 years ...<|control11|><|separator|>
  25. [25]
    The Average Age of Atrioventricular Block Onset in Middle Eastern ...
    Apr 25, 2024 · The average age at presentation with AVB in the ME is seven years younger than in other regions. While this is mostly driven by the overall younger population.
  26. [26]
    Trends in cardiovascular disease incidence among 22 ... - The BMJ
    Jun 26, 2024 · The incidence of coronary heart disease and stroke decreased by about 30% (incidence rate ratios for acute coronary syndrome, chronic ischaemic ...
  27. [27]
    Atrioventricular Block - Cardiovascular Disorders - Merck Manuals
    Up to one-third of patients age 18 years to 60 years with new-onset Mobitz II second-degree or third-degree AV block without evident structural heart disease ...Missing: prevalence | Show results with:prevalence<|separator|>
  28. [28]
    Risk Factors Associated With Atrioventricular Block - PMC
    May 24, 2019 · In this analysis of data from a population-based cohort study, suboptimal blood pressure and fasting glucose level were associated with AV block ...
  29. [29]
    Drug-induced atrioventricular block: prognosis after discontinuation ...
    Of 169 patients with AV block, 92 (54%) were receiving beta-blockers and/or verapamil or diltiazem. Patients receiving medications had similar clinical and ...
  30. [30]
    Drug-Induced Arrhythmias: A Scientific Statement From the ...
    Sep 15, 2020 · Digoxin toxicity can cause paroxysmal AT with atrioventricular block (Supplemental Figure 3) as a result of (1) inhibition of the Na+-K+-ATPase ...
  31. [31]
    Progressive familial heart block - Genetics - MedlinePlus
    The prevalence of progressive familial heart block is unknown. In the United States, about 1 in 5,000 individuals have complete heart block from any cause; ...Missing: population | Show results with:population
  32. [32]
    Mouse Model of SCN5A-Linked Hereditary Lenègre's Disease
    Apr 4, 2005 · Idiopathic progressive cardiac conduction disease, also known as Lenègre or Lev's disease, is characterized by an age-related alteration in the ...
  33. [33]
    Complete Heart Block Complicating ST-Segment Elevation ... - JACC
    Previous studies have reported the overall incidence of CHB in patients with AMI to be between 3% and 13% depending on the type and anatomical location of the ...
  34. [34]
    Site of Heart Block in Acute Myocardial Infarction | Circulation
    ... heart block in DMI is usually due to an ischemic lesion of the A-V node, while heart block in AMI is due to necrosis involving both bundle branches. Formats ...
  35. [35]
    Conduction abnormalities after myocardial infarction - UpToDate
    Sep 8, 2025 · INTRODUCTION. Electrical conduction abnormalities are well-recognized complications of acute myocardial infarction (MI).
  36. [36]
    Lyme Carditis - StatPearls - NCBI Bookshelf
    Atrioventricular block in Lyme carditis may range from first-degree to complete heart block, also known as third-degree atrioventricular block. The degree of ...
  37. [37]
    Lyme Disease and the Heart | Circulation
    Feb 19, 2013 · Heart block occasionally is complete and permanent, requiring insertion of a pacemaker. Myocarditis or pericarditis may occur. Death has been ...Total Citations56 · Lyme Carditis · Prevention Of Lyme Disease
  38. [38]
    When Should High-Grade Heart Block Trigger a Search for a ...
    Jun 1, 2011 · High-degree heart block is an uncommon manifestation of acute myocarditis in adults. The rate of heart block requiring a pacemaker in ...
  39. [39]
    Complete atrioventricular block after isolated aortic valve replacement
    Permanent complete AV block is a serious and rare complication. Its prevalence has been estimated at 3-6% of all patients undergoing aortic valve replacement.
  40. [40]
    Temporal Incidence and Predictors of High‐Grade Atrioventricular ...
    May 7, 2021 · In the present study, incidence of delayed HAVB (defined as >24 hours) was 3.7%, with the majority occurring in the first week after TAVR. The ...
  41. [41]
    hyperkalemia, the sodium potassium pump and the heart
    May 24, 2016 · Refractory periods can be absolute (ARP), effective (ERP) or relative (RRP). In an ARP, the cell is absolutely unexcitable.
  42. [42]
    Hyperkalaemia induced complete atrioventricular block with a ... - NIH
    High serum potassium levels are thought to impair the conduction in the Purkinje fibers and ventricles more than in the AV node, although complete ...
  43. [43]
    Atrioventricular block in patients with thyroid dysfunction
    Hypothyroidism is a reversible cause of atrioventricular (AV) block. Few reports have described reversible AV block caused by hyperthyroidism.
  44. [44]
    Pediatric Congenital Atrioventricular Block - Medscape Reference
    May 16, 2025 · Autoimmune AV block occurs in approximately 1 per 15,000-20,000 live births, and 1-2% of newborns whose mothers have positive anti-SSA-Ro ...
  45. [45]
    Complete congenital heart block in a neonate with a complex ...
    According to Kertesz et al., in various series of fetal congenital complete atrioventricular block, 30% to 53% of cases have associated congenital heart defect.Missing: percentage | Show results with:percentage<|separator|>
  46. [46]
    Clinical, Genetic, and Biophysical Characterization of SCN5A ...
    We present clinical, genetic, and biophysical features of 2 new SCN5A mutations that result in atrioventricular (AV) conduction block.
  47. [47]
    Kearns Sayre syndrome: a rare etiology of complete atrioventricular ...
    Kearns Sayre syndrome is a rare mitochondrial abnormality first described in 1958, characterized by a triad associating progressive external ophthalmoplegia ...
  48. [48]
    Heart Conduction Disorders | American Heart Association
    Sep 24, 2024 · Heart block is a delay in the electrical signals that progress from the heart's upper chambers (atria) to its lower chambers (ventricles). When ...
  49. [49]
    Third-Degree Atrioventricular Block - StatPearls - NCBI Bookshelf
    An atrioventricular block is a loss of the regular function of the cardiac electroconductive pathways linking the sinoatrial node (SA node) and the ventricles ...
  50. [50]
    Adams-Stokes Syndrome - MeSH - NCBI - NIH
    A condition of fainting spells caused by heart block, often an atrioventricular block, that leads to BRADYCARDIA and drop in CARDIAC OUTPUT.<|control11|><|separator|>
  51. [51]
    Heart block: MedlinePlus Medical Encyclopedia
    Apr 10, 2023 · Some normal people, will have a first degree block especially at rest or when asleep. This most often occurs in young healthy people.
  52. [52]
    Sick sinus syndrome - Symptoms & causes - Mayo Clinic
    Symptoms · A sensation of rapid, fluttering heartbeats (palpitations) · Chest pain or discomfort · Confusion · Dizziness or lightheadedness · Fainting or near ...Overview · Symptoms · When to see a doctor · Causes
  53. [53]
    A Wave - StatPearls - NCBI Bookshelf - NIH
    Jul 4, 2023 · Cannon A waves are large-amplitude waves seen in the jugular veins during a physical exam. They are caused by simultaneous contraction of atria and ventricle.Etiology · Pathophysiology · History and Physical · Evaluation
  54. [54]
    Third-Degree Atrioventricular Block (Complete Heart Block) Clinical ...
    Jul 29, 2022 · In particular, the physical examination findings of patients with third-degree AV block will be notable for bradycardia, which can be severe.
  55. [55]
    Second-Degree Atrioventricular Block - StatPearls - NCBI Bookshelf
    Continuing Education Activity. A delay in conduction between the atria and ventricles results in an atrioventricular conduction block.
  56. [56]
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management ...
    Nov 6, 2018 · ... Guideline Update for Implantation ... Complete atrioventricular block after valvular heart surgery and the timing of pacemaker implantation.
  57. [57]
    [PDF] 2018 Guideline on the Evaluation and Management of Patients With ...
    is slower than ventricular depolarization (from an atrioventricular nodal, His bundle, or ventricular site). •First-degree atrioventricular block: P waves ...
  58. [58]
    AV Block: 2nd degree, Mobitz I (Wenckebach Phenomenon) - LITFL
    A review of the basic ECG features, causes and pathophysiology of Mobitz I AV Block (Wenckebach Phenomenon) with some example ECGs.
  59. [59]
    ECG Diagnosis: Complete Heart Block - PMC - NIH
    Third-degree atrioventricular (AV) block (also referred to as complete heart block) is the complete dissociation of the atria and the ventricles.<|control11|><|separator|>
  60. [60]
    First-Degree Heart Block - StatPearls - NCBI Bookshelf - NIH
    First-degree atrioventricular (AV) block is a condition of abnormally slow conduction through the AV node.
  61. [61]
    Reversible Causes of Atrioventricular Block - PubMed
    Atrioventricular blocks may be caused by a variety of potentially reversible conditions, such as ischemic heart disease, electrolyte imbalances, medications, ...Missing: discontinue | Show results with:discontinue
  62. [62]
    Third-Degree Atrioventricular Block (Complete Heart Block ...
    Jul 29, 2022 · The first, and sometimes most important, medical treatment for heart block is the withdrawal of any potentially aggravating or causative medications.
  63. [63]
    Atropine Dose for Bradycardia | ACLS Guidelines
    If the patient is symptomatic, administer atropine 1.0 mg IV or IO bolus and repeat the atropine every 3 to 5 minutes to a total dose of 3 mg:
  64. [64]
    Heart block - Heart and Stroke Foundation of Canada
    Trained athletes and young people with a high vagal tone may also have first-degree heart block. There is one vagus nerve running from your brain to your ...
  65. [65]
    Congenital and childhood atrioventricular blocks: pathophysiology ...
    Jun 28, 2016 · The estimated prevalence of congenital heart block is 1 per 15,000–20,000 live births [64].Inherited Av Block · Permanent Pacemaker... · Endocardial Versus...
  66. [66]
    Long-term Outcomes in Individuals With Prolonged PR Interval or ...
    Jun 24, 2009 · Individuals with first-degree atrioventricular block had a 2-fold adjusted risk of AF (HR, 2.06; 95% CI, 1.36-3.12; P < .001), 3-fold adjusted ...
  67. [67]
    Second-Degree Atrioventricular Block - Medscape Reference
    Jun 28, 2022 · Mobitz type II AV block may progress to complete heart block, with an associated increased risk of mortality. Second degree AV block implies ...
  68. [68]
    Second-degree atrioventricular (AV) block - Mobitz Type II
    Mobitz type II second degree AV block is rarely seen in patients without underlying heart disease; It is associated with a high rate (>50%) of progression to ...
  69. [69]
    3rd Degree Heart Block: Causes, Symptoms, Outlook - Healthline
    Jan 9, 2023 · Third-degree heart block is the most serious type of heart block. Considered a medical emergency, it can be fatal without prompt treatment.Characteristics · Causes · Symptoms · Diagnosis
  70. [70]
    Long-term survival after pacemaker implantation for heart block in ...
    Observed survival at 1, 3, 5, and 10 years was 85%, 68%, 52%, 21%, and 72%, 50%, 31%, 11% for patients with isolated AV block and patients with coexisting heart ...
  71. [71]
    ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and ...
    Physiological AV block in the presence of supraventricular tachyarrhythmias is not an indication for pacemaker implantation except as specifically defined in ...
  72. [72]
    Third-Degree Atrioventricular Block (Complete Heart Block)
    Jul 29, 2022 · In most cases, AV block resolves promptly after revascularization, but sometimes the course is prolonged. Overall, the prognosis is favorable.Background · Pathophysiology · Etiology · Epidemiology
  73. [73]
    Sinoatrial block (SA block): ECG criteria, causes and clinical features
    Sinoatrial (SA) block implies that the impulses discharged in the sinoatrial node are either not conducted to the atria or are so with a delay.First-degree sinoatrial (SA) block · Second-degree sinoatrial (SA...Missing: pathophysiology | Show results with:pathophysiology
  74. [74]
    The long-term prognosis for patients with sinoatrial block treated ...
    Survival after one, two, five and eight years was calculated to 94, 85, 64 and 48%, respectively.
  75. [75]
    The Long-term Prognosis for Patients with Sinoatrial Block Treated ...
    Apr 24, 2009 · Survival after one, two, five and eight years was calculated to 94, 85, 64 and 48%, respectively.<|control11|><|separator|>
  76. [76]
    Sudden death in patients with chronic bifascicular block - PubMed
    We concluded that SCD is a major cause of mortality in patients with chronic bifascicular block. The association of SCD with coronary disease and ventricular ...
  77. [77]
    Heart Failure Due to High-Degree Atrioventricular Block - PubMed
    May 21, 2021 · Ventricular rate during AVB and LV ejection fraction were not significantly associated with the presence of HF. By multivariate nominal logistic ...
  78. [78]
    Annual Rate of Transvenous Defibrillation Lead Defects in ...
    Apr 30, 2007 · The annual failure rate increased with progressive time after implantation and reached 20% in 10-year-old leads (Figure 2).
  79. [79]
    Rates of and Factors Associated With Infection in 200 909 Medicare ...
    Jul 31, 2014 · The infection rate was 0.7% during the index hospitalization, 1.6% at 30 days, and 2.2% at 90 days. Using the Nationwide Inpatient Sample, ...
  80. [80]
    Atrial Standstill in the Pediatric Population: A Multi-Institution ... - JACC
    Oct 26, 2022 · Patients without the capacity for atrial pacing are at risk for thromboembolic events and warrant anticoagulation.Demographics And... · Clinical Course · Genetic Data